Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses

Immunity

Volumn 17, Issue 6, 2002, Pages 713-723

  Haas, Karen M ^a   Hasegawa, Minoru ^a   Steeber, Douglas A ^a   Poe, Jonathan C ^a   Zabel, Mark D ^b   Bock, Cheryl B ^a   Karp, David R ^c   Briles, David E ^d   Weis, John H ^b   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT RECEPTOR; IMMUNOGLOBULIN G3;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BACTERIUM; CELL MATURATION; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPLEEN; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE;

EID: 18744396051     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00483-1     Document Type: Article

References (47)

1. Ahearn J.M., Fischer M.B., Croix D., Goerg S., Ma M., Xia J., Zhou X., Howard R.G., Rothstein T.L., Carroll M.C. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity. 4:1996;251-262.
2. Bitter-Suermann D., Burger R. C3 deficiencies. Curr. Top. Microbiol. Immunol. 153:1989;223-233.
3. Botto M., Walport M.J. Hereditary deficiency of C3 in animals and humans. Int. Rev. Immunol. 10:1993;37-50.
4. Briles D.E., Benjamin W.H. Jr., Huster W.J., Posey B. Genetic approaches to the study of disease resistance. with special emphasis on the use of recombinant inbred mice Curr. Top. Microbiol. Immunol. 124:1986;21-35.
5. Brown E.J., Hosea S.W., Frank M.M. The role of complement in the localization of pneumococci in the splanchnic reticuloendothelial system during experimental bacteremia. J. Immunol. 126:1981;2230-2235.
6. Burman L.A., Norrby R., Trollfors B. Invasive pneumococcal infections. incidence, predisposing factors, and prognosis Rev. Infect. Dis. 7:1985;133-142.
7. Cariappa A., Tang M., Parng C., Nebelitskiy E., Carroll M., Georgopoulos K., Pillai S. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity. 14:2001;603-615.
8. -/- mice. enhanced affinity maturation but impaired antibody persistence J. Immunol. 164:2000;4522-4532.
9. Circolo A., Garnier G., Fukuda W., Wang X., Hidvegi T., Szalai A.J., Briles D.E., Volanakis J.E., Wetsel R.A., Colten H.R. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology. 42:1999;135-149.
10. Fang Y., Xu C., Fu Y.-X., Holers V.M., Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160:1998;5273-5279.
11. Fearon D.T., Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18:2000;393-422.
12. Figueroa J.E., Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:1991;359-395.
13. Fischer M.B., Ma M., Goerg S., Zhou X., Xia J., Finco O., Han S., Kelsoe G., Howard R.G., Rothstein T.L.et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:1996;549-556.
14. Greenspan N.S., Cooper L.J. Cooperative binding by mouse IgG3 antibodies. implications for functional affinity, effector function, and isotype restriction Springer Semin. Immunopathol. 15:1993;275-291.
15. Griffioen A.W., Rijkers G.T., Janssens-Korpela P., Zegers B.J. Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2. Infect. Immun. 59:1991;1839-1845.
16. Guinamard R., Okigaki M., Schlessinger J., Ravetch J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral responses. Nat. Immunol. 1:2000;31-36.
17. + B cells. Immunol. Rev. 137:1994;91-118.
18. Hasegawa M., Fujimoto M., Poe J.C., Steeber D.A., Tedder T.F. CD19 can regulate B lymphocyte signal transduction independent of complement activation. J. Immunol. 167:2001;3190-3200.
19. Hebell T., Ahearn J.M., Fearon D.T. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science. 254:1991;102-105.
20. Henson S.E., Smith D., Boackle S.A., Holers V.M., Karp D.R. Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function. J. Immunol. Methods. 258:2001;97-109.
21. Heyman B., Wiersma E.J., Kinoshita T. In vivo inhibition of the antibody response to a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:1990;665-668.
22. Kinoshita T., Takeda J., Hong K., Kozono H., Sakai H., Inoue K. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J. Immunol. 140:1988;3066-3073.
23. Kuijpers T.W., Weening R.S., Out T.A. IgG subclass deficiencies and recurrent pyogenic infections. unresponsiveness against bacterial polysaccharide antigens Allergol. Immunopathol. 20:1992;28-34.
24. Loder F., Mutschler B., Ray R.J., Paige C.J., Sideras P., Torres R., Lamers M.C., Carsetti R. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:1999;75-89.
25. Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 14:2001;617-629.
26. McLay J., Leonard E., Petersen S., Shapiro D., Greenspan N.S., Schreiber J.R. Gamma-3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1. J. Immunol. 168:2002;3437-3443.
27. Molina H., Holers V.M., Li B., Fang Y.-F., Mariathasan S., Goellner J., Strauss-Schoenberger J., Karr R.W., Chaplin D.D. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA. 93:1996;3357-3361.
28. Mori H., Sakamoto O., Xu Q.A., Daikoku M., Koda A. Solid phase enzyme-linked immunosorbent assay (ELISA) for anti-sheep erythrocyte antibody in mouse serum. Int. J. Immunopharmacol. 11:1989;597-606.
29. Ochsenbein A.F., Pinschewer D.D., Odermatt B., Carroll M.C., Hengartner H., Zinkernagel R.M. Protective T cell-independent antiviral antibody responses are dependent on complement. J. Exp. Med. 190:1999;1165-1174.
30. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162:1999;7198-7207.
31. Pepys M.B. Role of complement in induction of antibody production in vivo. Effect of cobra venom factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 140:1974;126-145.
32. Perlmutter R.M., Hansburg D., Briles D.E., Nicolotti R.A., Davie J.M. Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 121:1978;566-572.
33. Peset Llopis M.J., Harms G., Hardonk M.J., Timens W. Human immune response to pneumococcal polysaccharides. complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells J. Allergy Clin. Immunol. 97:1996;1015-1024.
34. Poe J.C., Hasegawa M., Tedder T.F. CD19, CD21 and CD22. multifaceted response regulators of B lymphocyte signal transduction Int. Rev. Immunol. 20:2001;739-762.
35. Pryjma J., Humphrey J.H., Klaus G.G. C3 activation and T-independent B cell stimulation. Nature. 252:1974;505-506.
36. Rickert R.C., Rajewsky K., Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature. 376:1995;352-355.
37. Sato S., Ono N., Steeber D.A., Pisetsky D.S., Tedder T.F. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157:1996;4371-4378.
38. Selfridge J., Pow A.M., McWhir J., Magin T.M., Melton D.W. Gene targeting using a mouse HPRT minigene/HPRT-deficient embryonic stem cell system. inactivation of the mouse ERCC-1 gene Somat. Cell Molec. Genet. 18:1992;325-336.
39. Shackelford P.G., Nelson S.J., Palma A.T., Nahm M.H. Human antibodies to group A streptococcal carbohydrate. Ontogeny, subclass restriction, and clonal diversity. J. Immunol. 140:1988;3200-3205.
40. Test S.T., Mitsuyoshi J., Connolly C.C., Lucas A.H. Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide. Infect. Immun. 69:2001;3031-3040.
41. Thornton B.P., Vetvicka V., Ross G.D. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152:1994;1727-1737.
42. Thyphronitis G., Kinoshita T., Inoue K., Schweinle J.E., Tsokos G.C., Metcalf E.S., Finkelman F.D., Balow J.E. Modulation of mouse complement receptors 1 and 2 suppress antibody responses in vivo. J. Immunol. 147:1991;224-230.
43. Timens W., Boes A., Rozeboom-Uiterwijk T., Poppema S. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J. Immunol. 143:1989;3200-3206.
44. Wardemann H., Boehm T., Dear N., Carsetti R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J. Exp. Med. 195:2002;771-780.
45. Wessels M.R., Butko P., Ma M., Warren H.B., Lage A., Carroll M.C. Studies of group B streptococcal infection in mice deficient in complement C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA. 92:1995;11490-11494.
46. Winkelstein J.A. The role of complement in the host's defense against Streptococcus pneumoniae. Rev. Infect. Dis. 3:1981;289-298.
47. -/- mice is rescued by adjuvants without improvement in germinal center development. J. Immunol. 165:2000;3119-3127.